000 | 01256 a2200385 4500 | ||
---|---|---|---|
005 | 20250512121002.0 | ||
264 | 0 | _c19730731 | |
008 | 197307s 0 0 fre d | ||
022 | _a0041-4131 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBen-Ismail, M | |
245 | 0 | 0 |
_a[Clinical trial of baronorm in the treatment of hypertension]. _h[electronic resource] |
260 |
_bLa Tunisie medicale _c |
||
300 |
_a145-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntihypertensive Agents _xtherapeutic use |
650 | 0 | 4 |
_aBenzothiadiazines _xadverse effects |
650 | 0 | 4 |
_aConstipation _xchemically induced |
650 | 0 | 4 |
_aCyclic S-Oxides _xadverse effects |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypertension _xdrug therapy |
650 | 0 | 4 |
_aHypotension, Orthostatic _xchemically induced |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPropylene Glycols _xadverse effects |
650 | 0 | 4 |
_aSecologanin Tryptamine Alkaloids _xadverse effects |
650 | 0 | 4 |
_aTheophylline _xadverse effects |
650 | 0 | 4 |
_aUremia _xchemically induced |
700 | 1 | _aGirardet, J P | |
773 | 0 |
_tLa Tunisie medicale _gvol. 50 _gno. 2 _gp. 145-8 |
|
999 |
_c4665412 _d4665412 |